NH.NSE · Narayana Hrudayalaya Limited

-

Please sign in to comment on NH.NSE

1 Comment

Admin

4 years ago

Narayana Hrudayalaya Limited is currently in a long term uptrend where the price is trading 13.9% above its 200 day moving average.

From a valuation standpoint, the stock is 29.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.

Narayana Hrudayalaya Limited's total revenue sank by 5.5% to $29B since the same quarter in the previous year.

Its net income has dropped by 5.7% to $12B since the same quarter in the previous year.

Finally, its free cash flow grew by 100.6% to $19B since the same quarter in the previous year.

Based on the above factors, Narayana Hrudayalaya Limited gets an overall score of 3/5.

Exchange	NSE
CurrencyCode	INR
Sector	Healthcare
Industry	Medical Care Facilities
ISIN	INE410P01011

Beta	0.21
Market Cap	366B
PE Ratio	46.73
Target Price	1453.8462
Dividend Yield	0.2%

ABOUT

Narayana Hrudayalaya Limited

Narayana Hrudayalaya Limited engages in the medical and healthcare services in India and internationally. It operates through two segments, Medical and Healthcare Related Services; and Others. The company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centres, nursing homes and other related activities. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology services. The company engages in health insurance business. The company was incorporated in 2000 and is headquartered in Bengaluru, India.

NH.NSE · Narayana Hrudayalaya Limited

-

Narayana Hrudayalaya Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Narayana Hrudayalaya Limited using a moving average strategy